Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)

• Status: Completed
• Trial end date: 2015-09-01

Summary

The purpose of this study is to evaluate the ability of PRT064445 to reverse the effects of several blood thinner drugs on laboratory tests. The study also is evaluating the blood levels of PRT064445 given at different doses.

• Phase: Phase 2

Details

• Lead Sponsor: Portola Pharmaceuticals
• Treatments: Enoxaparin; Enoxaparin sodium